本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

24.36
+0.86003.66%
盤後24.670.3100+1.27%19:47 EST
成交量:72.32萬
成交額:1,764.87萬
市值:18.90億
市盈率:-12.16
高:25.02
開:23.47
低:23.03
收:23.50
52周最高:31.35
52周最低:10.91
股本:7,759.21萬
流通股本:6,382.98萬
量比:1.38
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-2.0036
每股收益(LYR):-3.1802
淨資產收益率:-38.08%
總資產收益率:-30.20%
市淨率:6.32
市盈率(LYR):-7.66

資料載入中...

2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC問詢函

Form CORRESP - Correspondence
2024/04/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/29

SEC問詢函

Form CORRESP - Correspondence
2024/03/27

SEC問詢函

Form CORRESP - Correspondence
2024/03/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

SEC問詢函

Form CORRESP - Correspondence
2024/03/14

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/03/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]